Multiple Sclerosis Therapies Market Share, Size, Structure, Demands, Challenges and Opportunities by 2020-2025
According to IMARC Group’s latest report, titled “Multiple Sclerosis Therapies Market Share, Global Industry Trends, Size, Growth, Opportunity and Forecast 2020-2025”, The global multiple sclerosis therapies market experienced moderate growth during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during the next five years.
Multiple sclerosis (MS) is a severe inflammatory immune-mediated condition that may cause axonal transection, demyelination and neurodegeneration of the nerve cells in the brain and spinal cord. Some of the commonly used therapies to treat MS include oral and infused medicines, administration of injectables, antidepressants, muscle relaxants and physical therapy. Multiple sclerosis therapies help in managing the symptoms to reduce the frequency of the relapses and control the heart rate and blood pressure of the patient.
The growing prevalence of primary-progressive multiple sclerosis, secondary-progressive multiple sclerosis, and progressive-relapsing multiple sclerosis across the globe is primarily driving the demand for MS therapies. Furthermore, the increasing geriatric population, who are more prone to multiple sclerosis, is also providing a thrust to the market. Besides this, the healthcare providers are widely utilizing immunosuppressants that control autoimmune attacks and lower relapses among patients suffering from multiple sclerosis. Additionally, numerous technological advancements, such as the development of innovative monoclonal bodies, immunosuppressants, immunomodulators, and interferons for the effective treatment of multiple sclerosis, are further augmenting the market growth. Moreover, governments of several countries are launching campaigns to spread awareness regarding the available treatment alternatives among the masses, which is expected to further propel the market in the coming years.
Get a PDF sample of this report for detailed market insights: https://www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsample
Multiple Sclerosis Therapies Market 2020-2025 Competitive Analysis and Segmentation:
The competitive landscape of the multiple sclerosis therapies market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbvie Inc.
- Bayer Aktiengesellschaft
- Biogen Inc.
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG (Roche Holding AG)
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Novartis AG
- Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
The report has segmented the global multiple sclerosis therapies market on the basis of drug, drug type, route of administration, distribution channel and region.
Breakup by Drug:
Breakup by Drug Type:
- Biologic Drugs
- Small Molecule Drugs
Breakup by Route of Administration:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America
- United States
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Explore report description with table of contents: https://www.imarcgroup.com/multiple-sclerosis-therapies-market
Key highlights of the report:
- Market Performance (2014-2019)
- Market Outlook (2020-2025)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Negative Pressure Wound Therapy Market: https://www.imarcgroup.com/negative-pressure-wound-therapy-market
Bioinformatics Market: https://www.imarcgroup.com/bioinformatics-market
Oncology Active Pharmaceutical Ingredients Market: https://www.imarcgroup.com/oncology-active-pharmaceutical-ingredients-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.